| 摘要 |
Disclosed Is a composition or a pharmaceutical composition in dry powder form, for assisting mucus clearance, comprising at least one glycosaminoglycan and an amino acid. The glycosaminogly can be a heparin and/or a heparinoid, such as danaparoid sodium, chondroitin, or dermatan sulfate. Also disclosed is the suitability of the above composition for treating pulmonary diseases such chronic bronchitis, acute asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) or bronchiectasis. Also disclosed is a method of making the dry powder, using either spray drying or jet milling.
|
